Michael Roth has served as Vice President of Quality at Nurix since May 2024. Mr. Roth has over 30 years of pharmaceutical experience overseeing all aspects of quality assurance and compliance, as well as extensive experience managing PAI/BIMO inspections and commercial activities. Prior to joining Nurix, Mr. Roth served as Vice President of Quality Assurance at Rain Oncology, where he managed the quality groups and supported the company’s clinical and non-clinical studies. Previously, he served as Vice President of Quality Assurance at Principia Biopharma, Executive Director of Quality Assurance at Rigel Pharmaceuticals, and Director of Quality Control and Assurance at Zosano Pharma. He has collaborated on three drugs that received FDA approval. Mr. Roth holds a B.A. in Chemistry from the State University College of Buffalo and an M.A. in Pharmacology from the State University of New York at Buffalo (RPMI).
'